Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Slifstein

Showing results (31-40 of 131) with videos related to

Pageof 14
Sort By:
Molecular Psychiatry|November 6, 2020
Imaging synaptic dopamine availability in individuals at clinical high-risk for psychosis: a [<sup>11</sup>C]-(+)-PHNO PET with methylphenidate challenge studyRagy R Girgis, Mark Slifstein, Gary Brucato, et al.
Depression and Anxiety|January 31, 2009
Dopamine transporters, D2 receptors, and dopamine release in generalized social anxiety disorderFranklin R Schneier, Anissa Abi-Dargham, Diana Martinez, et al.
JAMA Psychiatry|May 5, 2016
Dopamine-Related Disruption of Functional Topography of Striatal Connections in Unmedicated Patients With SchizophreniaGuillermo Horga, Clifford M Cassidy, Xiaoyan Xu, et al.
Drug and Alcohol Dependence|November 1, 2019
Binge alcohol use is not associated with alterations in striatal dopamine receptor binding or dopamine releaseJonathan M Wai, Alexander Grassetti, Mark Slifstein, et al.
Synapse (New York, N.Y.)|September 5, 2006
Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivoRajesh Narendran, Mark Slifstein, Olivier Guillin, et al.
Synapse (New York, N.Y.)|May 4, 2011
Characterization of in vivo pharmacological properties and sensitivity to endogenous serotonin of [11C] P943: a positron emission tomography study in Papio anubisKhanum Ridler, Christophe Plisson, Eugenii A Rabiner, et al.
The American Journal of Psychiatry|September 3, 2009
Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D(2)/D(3) receptors following acute dopamine depletionDiana Martinez, Kaitlin Greene, Allegra Broft, et al.
Schizophrenia Research|July 21, 2015
Antipsychotic binding to the dopamine-3 receptor in humans: A PET study with [(11)C]-(+)-PHNORagy R Girgis, Xiaoyan Xu, Roberto B Gil, et al.
Nuclear Medicine and Biology|October 7, 2004
In vivo evaluation of [11C]N-(2-chloro-5-thiomethylphenyl)-N'-(3-methoxy-phenyl)-N'-methylguanidine ([11C]GMOM) as a potential PET radiotracer for the PCP/NMDA receptorRikki N Waterhouse, Mark Slifstein, Filip Dumont, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 24, 2010
In vivo binding of antipsychotics to D3 and D2 receptors: a PET study in baboons with [11C]-(+)-PHNORagy R Girgis, Xiaoyan Xu, Nobumi Miyake, et al.
Pageof 14

Showing results (31-40 of 131) with videos related to

Sort By:
Pageof 14
Molecular Psychiatry|November 6, 2020
Imaging synaptic dopamine availability in individuals at clinical high-risk for psychosis: a [<sup>11</sup>C]-(+)-PHNO PET with methylphenidate challenge studyRagy R Girgis, Mark Slifstein, Gary Brucato, et al.
Depression and Anxiety|January 31, 2009
Dopamine transporters, D2 receptors, and dopamine release in generalized social anxiety disorderFranklin R Schneier, Anissa Abi-Dargham, Diana Martinez, et al.
JAMA Psychiatry|May 5, 2016
Dopamine-Related Disruption of Functional Topography of Striatal Connections in Unmedicated Patients With SchizophreniaGuillermo Horga, Clifford M Cassidy, Xiaoyan Xu, et al.
Drug and Alcohol Dependence|November 1, 2019
Binge alcohol use is not associated with alterations in striatal dopamine receptor binding or dopamine releaseJonathan M Wai, Alexander Grassetti, Mark Slifstein, et al.
Synapse (New York, N.Y.)|September 5, 2006
Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivoRajesh Narendran, Mark Slifstein, Olivier Guillin, et al.
Synapse (New York, N.Y.)|May 4, 2011
Characterization of in vivo pharmacological properties and sensitivity to endogenous serotonin of [11C] P943: a positron emission tomography study in Papio anubisKhanum Ridler, Christophe Plisson, Eugenii A Rabiner, et al.
The American Journal of Psychiatry|September 3, 2009
Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D(2)/D(3) receptors following acute dopamine depletionDiana Martinez, Kaitlin Greene, Allegra Broft, et al.
Schizophrenia Research|July 21, 2015
Antipsychotic binding to the dopamine-3 receptor in humans: A PET study with [(11)C]-(+)-PHNORagy R Girgis, Xiaoyan Xu, Roberto B Gil, et al.
Nuclear Medicine and Biology|October 7, 2004
In vivo evaluation of [11C]N-(2-chloro-5-thiomethylphenyl)-N'-(3-methoxy-phenyl)-N'-methylguanidine ([11C]GMOM) as a potential PET radiotracer for the PCP/NMDA receptorRikki N Waterhouse, Mark Slifstein, Filip Dumont, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 24, 2010
In vivo binding of antipsychotics to D3 and D2 receptors: a PET study in baboons with [11C]-(+)-PHNORagy R Girgis, Xiaoyan Xu, Nobumi Miyake, et al.
Pageof 14